Osteoarthritis of Hip Clinical Trial
Official title:
The Viability of Short Stems in Total Hip Arthroplasty
NCT number | NCT02577822 |
Other study ID # | STU00082654 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | October 2013 |
Est. completion date | July 2019 |
Verified date | January 2020 |
Source | Northwestern University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this study is to determine the viability of short femoral stems as an alternative to standard-length stems in total hip arthroplasty.
Status | Completed |
Enrollment | 60 |
Est. completion date | July 2019 |
Est. primary completion date | August 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 85 Years |
Eligibility |
Inclusion Criteria: - Must require a total hip arthroplasty. - Ages 18-85 years, regardless of gender, ethnicity, or pathology Exclusion Criteria: - This study excludes any populations at risk. - Minors, as well as any persons unable to consent, will not be eligible. |
Country | Name | City | State |
---|---|---|---|
United States | Northwestern Medicine Department of Orthopaedic Surgery | Chicago | Illinois |
Lead Sponsor | Collaborator |
---|---|
Northwestern University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Mean VR-12 Mental Composite Score Through 2 Years Post Operative | Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients. | Assesed pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | |
Primary | Mean VR-12 Physical Composite Score Through 2 Years Post Operative | Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (PCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients. | Assessed pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | |
Primary | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain higher scores indicate more frequent and severe incidence of pain during daily activities | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | |
Primary | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | |
Primary | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain higher scores indicated greater impact on patient's ability to perform daily activities and social function | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | |
Secondary | EBRA (Ein-Bild-Roentgen-Analyse) Femoral Component Analysis (EBRA-FCA) of Implant Subsidence Through 2 Years Post Operative | EBRA-FCA is a commonly employed technique to evaluate implant migration via radiographic measurements taken over the duration of recovery. The mean subsidence values measured in millimeters were recorded for both the short and standard stem cohorts at each of the clinic visits for SOC. Of note, the individual responsible for performing and recording these measurements could not be reached during upload of the final study data and consequently the dispersion values for this measure were not available at the time of publication. The dispersion values for these measures have been recorded as '0' for each time point pending any response from the individual to obtain the original data. |
Assessed 6 weeks post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02405104 -
Chlorzoxazone in Hip and Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT02162186 -
Clinical and Radiographic Outcomes of the Corin Tri-Fit Total Hip Replacement
|
||
Active, not recruiting |
NCT02263209 -
Investigation to Determine Safety of Taperloc Stems With BioGuard Coating When Used in Cementless Total Hip Arthroplasty
|
N/A | |
Active, not recruiting |
NCT00551967 -
Evaluation of the Wear of Vitamin E Treated Polyethylene Components in Primary THA Using RSA
|
N/A | |
Active, not recruiting |
NCT00545285 -
Long-Term Multi-center Evaluation of E-Poly and Regenerex
|
N/A | |
Completed |
NCT03966573 -
Femoral Lengthening Might Impair Physical Function and Lead to Structural Changes in Adjacent Joints
|
N/A | |
Recruiting |
NCT04754087 -
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study
|
N/A | |
Completed |
NCT00957970 -
Bone Mineral Changes Around Stemless and Stemmed Cementless Femoral Components
|
Phase 4 | |
Completed |
NCT00565786 -
ArCom® and ArComXL® Polyethylene Data Collection
|
||
Completed |
NCT03428893 -
Mobile Technology to Support Physical Therapy Exercise
|
N/A | |
Terminated |
NCT02161484 -
Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement
|
N/A | |
Completed |
NCT01972594 -
Pedometer Based Intervention After Total Hip Replacement-A Pilot Study
|
N/A | |
Withdrawn |
NCT01668160 -
Stability of Revision Total Hip Arthroplasty Implants Using Radiostereometric Analysis
|
N/A | |
Not yet recruiting |
NCT01040273 -
Management of Postoperative Pain After Total Hip Arthroplasty
|
Phase 2/Phase 3 | |
Recruiting |
NCT02836262 -
Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty
|
N/A | |
Completed |
NCT03341442 -
A Study of Posterior Hip Precautions After Total Hip Arthroplasty
|
N/A |